Low levels of zinc in the blood is associated with an increased risk of death in patients with COVID-19. Low levels of plasma zinc also correlate with higher inflammation and poorer outcome.
Lower level of zinc in the blood is associated with a poorer outcome in COVID-19 patients, according to a new study. It is known that increased level of intracellular zinc concentrations efficiently impairs replication of several viruses.
‘A plasma zinc level below 50 mcg/dl at admission into a hospital is associated with 2.3 times higher risk of in-hospital death compared to those patients with a plasma zinc level of 50mcg/dl or higher. A single unit increase of plasma zinc was also associated with a 7% reduced risk of in-hospital mortality. Further studies are needed to assess the therapeutic impact of this association.’
Read More..
The researchers performed a retrospective analysis of symptomatic patients admitted to a tertiary university hospital in Barcelona, Spain from 15th March 2020 to 30th April 2020. Read More..
Various data on demography, laboratory results, pre-existing chronic conditions and treatment were collected by the researchers.
Clinical severity of COVID-19 and the levels of fasting plasma zinc levels were assessed routinely at admission in all patients admitted to the COVID-19 Unit.
Statistical analyses and computer modelling were used to assess the impact of zinc on COVID-19 mortality.
A total of 611 patients were admitted during this period, with a mean age of 63 years. 55% of the patients were male, and 87 patients died during this period.
Advertisement
The researchers found that the patients had a mean baseline zinc level of 61 mcg/dl. The patients who died had a significantly lower baseline level of 43 mcg/dl.
Advertisement
A single unit increase of plasma zinc was associated with a 7% reduced risk of in-hospital mortality after factors like by age, sex, severity and receiving hydroxychloroquine, and statistical analysis were adjusted.
A plasma zinc level below 50 mcg/dl at admission was associated with 2.3 times higher risk of in-hospital death compared with those patients with a plasma zinc level of 50mcg/dl or higher.
"Lower zinc levels at admission correlate with higher inflammation in the course of infection and poorer outcome. Plasma zinc levels at admission are associated with mortality in COVID-19 in our study. Further studies are needed to assess the therapeutic impact of this association," the authors concluded.
Source-Medindia